Reuters logo
BRIEF-Sinclair IS Pharma sees strong H2 delivering in-line results
January 16, 2014 / 7:31 AM / 4 years ago

BRIEF-Sinclair IS Pharma sees strong H2 delivering in-line results

Jan 16 (Reuters) - Sinclair IS Pharma PLC : * Revenues for H1 expected to be approximately £24.5 million (£23.0 million H1

FY 2013) * Strong H2 expected to produce c7% lfl growth

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below